short acting glp 1 agonists Comparison of short-acting versus long-acting GLP-1 RAs [Meier et al Comparison Review of Short-Acting and
Description
It causes sudden, painless vision loss in one eye with irreparable damage to the nerve and impacts the eyes connection to the brain

10.1358/dof.2019.44.6.2927591

Abstract The ever-increasing number of drugs available to treat type 2 diabetes and the complexity of patients with this condition present a constant challenge when it comes to identifying the most appropriate treatment approach

doi: 10.1523/JNEUROSCI.5855-12.2013 104 KnightR.CallewaertC.MarotzC.HydeE

The corresponding 10-year estimates were 75.5% and 73.4%, respectively
[DOI] [PubMed] [Google Scholar] Liang Y
